List of Tables
    Table 1. Sexually Transmitted Diseases Drug CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Sexually Transmitted Diseases Drug Market Trends
    Table 3. Sexually Transmitted Diseases Drug Market Drivers
    Table 4. Sexually Transmitted Diseases Drug Market Challenges
    Table 5. Sexually Transmitted Diseases Drug Market Restraints
    Table 6. Global Sexually Transmitted Diseases Drug Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Sexually Transmitted Diseases Drug Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Sexually Transmitted Diseases Drug Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Sexually Transmitted Diseases Drug Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Sexually Transmitted Diseases Drug Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Sexually Transmitted Diseases Drug Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Sexually Transmitted Diseases Drug Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Sexually Transmitted Diseases Drug Sales by Manufacturer, (MT), 2017-2022
    Table 14. Global Sexually Transmitted Diseases Drug Sales Share by Manufacturer, 2017-2022
    Table 15. Global Sexually Transmitted Diseases Drug Price by Manufacturer (2017-2022) & (USD/Kg)
    Table 16. Global Sexually Transmitted Diseases Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Sexually Transmitted Diseases Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sexually Transmitted Diseases Drug as of 2021)
    Table 18. Top Players of Sexually Transmitted Diseases Drug in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Sexually Transmitted Diseases Drug Product Type
    Table 20. Date of International Manufacturers Enter into Sexually Transmitted Diseases Drug Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Sexually Transmitted Diseases Drug Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Sexually Transmitted Diseases Drug Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Sexually Transmitted Diseases Drug Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Sexually Transmitted Diseases Drug Sales by Players, (MT), 2020, 2021 & 2022
    Table 26. United States Sexually Transmitted Diseases Drug Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Sexually Transmitted Diseases Drug Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Sexually Transmitted Diseases Drug Sales in Volume by Region (2017-2022) & (MT)
    Table 29. Global Sexually Transmitted Diseases Drug Sales in Volume Forecast by Region (2023-2028) & (MT)
    Table 30. Global Sexually Transmitted Diseases Drug Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Sexually Transmitted Diseases Drug Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Sexually Transmitted Diseases Drug Sales in Volume by Country (2017-2028) & (MT)
    Table 33. North America Sexually Transmitted Diseases Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Sexually Transmitted Diseases Drug Sales in Volume by Region (2017-2028) & (MT)
    Table 35. Asia Pacific Sexually Transmitted Diseases Drug Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Sexually Transmitted Diseases Drug Sales in Volume by Country (2017-2028) & (MT)
    Table 37. Europe Sexually Transmitted Diseases Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Sexually Transmitted Diseases Drug Sales in Volume by Country (2017-2028) & (MT)
    Table 39. Latin Americaa Sexually Transmitted Diseases Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Sexually Transmitted Diseases Drug Sales in Volume by Country (2017-2028) & (MT)
    Table 41. Middle East and Africa Sexually Transmitted Diseases Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Pfizer INC Corporation Information
    Table 43. Pfizer INC Description and Business Overview
    Table 44. Pfizer INC Sexually Transmitted Diseases Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 45. Pfizer INC Sexually Transmitted Diseases Drug Product
    Table 46. Pfizer INC Recent Development
    Table 47. Merck & Co. Corporation Information
    Table 48. Merck & Co. Description and Business Overview
    Table 49. Merck & Co. Sexually Transmitted Diseases Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 50. Merck & Co. Product
    Table 51. Merck & Co. Recent Development
    Table 52. Gilead Sciences Corporation Information
    Table 53. Gilead Sciences Description and Business Overview
    Table 54. Gilead Sciences Sexually Transmitted Diseases Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 55. Gilead Sciences Product
    Table 56. Gilead Sciences Recent Development
    Table 57. Hoffmann La Roche Corporation Information
    Table 58. Hoffmann La Roche Description and Business Overview
    Table 59. Hoffmann La Roche Sexually Transmitted Diseases Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 60. Hoffmann La Roche Product
    Table 61. Hoffmann La Roche Recent Development
    Table 62. Bayer Healthcare Corporation Information
    Table 63. Bayer Healthcare Description and Business Overview
    Table 64. Bayer Healthcare Sexually Transmitted Diseases Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 65. Bayer Healthcare Product
    Table 66. Bayer Healthcare Recent Development
    Table 67. Eli Lilly Corporation Information
    Table 68. Eli Lilly Description and Business Overview
    Table 69. Eli Lilly Sexually Transmitted Diseases Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 70. Eli Lilly Product
    Table 71. Eli Lilly Recent Development
    Table 72. Bristol-Myers Squibb Co. AbbVie Corporation Information
    Table 73. Bristol-Myers Squibb Co. AbbVie Description and Business Overview
    Table 74. Bristol-Myers Squibb Co. AbbVie Sexually Transmitted Diseases Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 75. Bristol-Myers Squibb Co. AbbVie Product
    Table 76. Bristol-Myers Squibb Co. AbbVie Recent Development
    Table 77. Johnson & Johnson Corporation Information
    Table 78. Johnson & Johnson Description and Business Overview
    Table 79. Johnson & Johnson Sexually Transmitted Diseases Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 80. Johnson & Johnson Product
    Table 81. Johnson & Johnson Recent Development
    Table 82. GlaxoSmithKline Plc Corporation Information
    Table 83. GlaxoSmithKline Plc Description and Business Overview
    Table 84. GlaxoSmithKline Plc Sexually Transmitted Diseases Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 85. GlaxoSmithKline Plc Product
    Table 86. GlaxoSmithKline Plc Recent Development
    Table 87. Key Raw Materials Lists
    Table 88. Raw Materials Key Suppliers Lists
    Table 89. Sexually Transmitted Diseases Drug Customers List
    Table 90. Sexually Transmitted Diseases Drug Distributors List
    Table 91. Research Programs/Design for This Report
    Table 92. Key Data Information from Secondary Sources
    Table 93. Key Data Information from Primary Sources
List of Figures
    Figure 1. Sexually Transmitted Diseases Drug Product Picture
    Figure 2. Global Sexually Transmitted Diseases Drug Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Sexually Transmitted Diseases Drug Market Size 2017-2028 (US$ Million)
    Figure 4. Global Sexually Transmitted Diseases Drug Sales 2017-2028 (MT)
    Figure 5. United States Sexually Transmitted Diseases Drug Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Sexually Transmitted Diseases Drug Market Size 2017-2028 (US$ Million)
    Figure 7. United States Sexually Transmitted Diseases Drug Sales 2017-2028 (MT)
    Figure 8. United States Sexually Transmitted Diseases Drug Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Sexually Transmitted Diseases Drug Market Share in Global, in Volume (MT) 2017-2028
    Figure 10. Sexually Transmitted Diseases Drug Report Years Considered
    Figure 11. Product Picture of Antiviral / Antiretrovirals
    Figure 12. Product Picture of Antibiotics
    Figure 13. Product Picture of Vaccines
    Figure 14. Global Sexually Transmitted Diseases Drug Market Share by Type in 2022 & 2028
    Figure 15. Global Sexually Transmitted Diseases Drug Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 16. Global Sexually Transmitted Diseases Drug Sales Market Share in Value by Type (2017-2028)
    Figure 17. Global Sexually Transmitted Diseases Drug Sales by Type (2017-2028) & (MT)
    Figure 18. Global Sexually Transmitted Diseases Drug Sales Market Share in Volume by Type (2017-2028)
    Figure 19. Global Sexually Transmitted Diseases Drug Price by Type (2017-2028) & (USD/Kg)
    Figure 20. United States Sexually Transmitted Diseases Drug Market Share by Type in 2022 & 2028
    Figure 21. United States Sexually Transmitted Diseases Drug Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 22. United States Sexually Transmitted Diseases Drug Sales Market Share in Value by Type (2017-2028)
    Figure 23. United States Sexually Transmitted Diseases Drug Sales by Type (2017-2028) & (MT)
    Figure 24. United States Sexually Transmitted Diseases Drug Sales Market Share in Volume by Type (2017-2028)
    Figure 25. United States Sexually Transmitted Diseases Drug Price by Type (2017-2028) & (USD/Kg)
    Figure 26. Product Picture of Hospital
    Figure 27. Product Picture of Cinic
    Figure 28. Product Picture of Other
    Figure 29. Global Sexually Transmitted Diseases Drug Market Share by Application in 2022 & 2028
    Figure 30. Global Sexually Transmitted Diseases Drug Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 31. Global Sexually Transmitted Diseases Drug Sales Market Share in Value by Application (2017-2028)
    Figure 32. Global Sexually Transmitted Diseases Drug Sales by Application (2017-2028) & (MT)
    Figure 33. Global Sexually Transmitted Diseases Drug Sales Market Share in Volume by Application (2017-2028)
    Figure 34. Global Sexually Transmitted Diseases Drug Price by Application (2017-2028) & (USD/Kg)
    Figure 35. United States Sexually Transmitted Diseases Drug Market Share by Application in 2022 & 2028
    Figure 36. United States Sexually Transmitted Diseases Drug Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 37. United States Sexually Transmitted Diseases Drug Sales Market Share in Value by Application (2017-2028)
    Figure 38. United States Sexually Transmitted Diseases Drug Sales by Application (2017-2028) & (MT)
    Figure 39. United States Sexually Transmitted Diseases Drug Sales Market Share in Volume by Application (2017-2028)
    Figure 40. United States Sexually Transmitted Diseases Drug Price by Application (2017-2028) & (USD/Kg)
    Figure 41. North America Sexually Transmitted Diseases Drug Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 42. North America Sexually Transmitted Diseases Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 43. U.S. Sexually Transmitted Diseases Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Canada Sexually Transmitted Diseases Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Europe Sexually Transmitted Diseases Drug Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 46. Europe Sexually Transmitted Diseases Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. Germany Sexually Transmitted Diseases Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. France Sexually Transmitted Diseases Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. U.K. Sexually Transmitted Diseases Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Italy Sexually Transmitted Diseases Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Russia Sexually Transmitted Diseases Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Asia-Pacific Sexually Transmitted Diseases Drug Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 53. Asia-Pacific Sexually Transmitted Diseases Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 54. China Sexually Transmitted Diseases Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Japan Sexually Transmitted Diseases Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. South Korea Sexually Transmitted Diseases Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. India Sexually Transmitted Diseases Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Australia Sexually Transmitted Diseases Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Taiwan Sexually Transmitted Diseases Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Indonesia Sexually Transmitted Diseases Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Thailand Sexually Transmitted Diseases Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Malaysia Sexually Transmitted Diseases Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Philippines Sexually Transmitted Diseases Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Latin America Sexually Transmitted Diseases Drug Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 65. Latin America Sexually Transmitted Diseases Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 66. Mexico Sexually Transmitted Diseases Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Brazil Sexually Transmitted Diseases Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Argentina Sexually Transmitted Diseases Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Middle East & Africa Sexually Transmitted Diseases Drug Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 70. Middle East & Africa Sexually Transmitted Diseases Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 71. Turkey Sexually Transmitted Diseases Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Saudi Arabia Sexually Transmitted Diseases Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. U.A.E Sexually Transmitted Diseases Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Sexually Transmitted Diseases Drug Value Chain
    Figure 75. Sexually Transmitted Diseases Drug Production Process
    Figure 76. Channels of Distribution
    Figure 77. Distributors Profiles
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed